Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -14 % |
3 Month Return | -10.97 % |
1 Year Return | + 16.27 % |
Market Stats | |
Previous Close | ₹54.53 |
Open | ₹54.60 |
Volume | 5,413.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹152.43Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹152.43 Cr |
P/B Ratio | 0.98 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 3.74 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹152.43 Cr | 5.16% | 0.60 | NA | NA | |
NA | ₹64.17 Cr | 258.28% | 0.50 | NA | NA | |
NA | ₹123.98 Cr | 53.7% | 0.69 | NA | NA | |
NA | ₹94.27 Cr | 188.71% | 0.51 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr |
Organisation | Aarey Drugs & Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Aarey Drugs & Pharmaceuticals Ltd
Investors are less pessimistic than expected, leading to a sharp annual gain of 84%. However, the company's P/E ratio of 47.4x is concerning compared to the market in India, where half of companies have P/Es below 31x.
Aarey Drugs & Pharmaceuticals Ltd's Debt Levels Not Problematic - 22 Mar, 2024
Aarey Drugs & Pharmaceuticals has liabilities of ₹1.10b due within a year, but also has ₹316.6m more liquid assets than total liabilities. Its debt to EBITDA ratio is 3.5 and its EBIT covered interest expense 5.8 times. The company grew its EBIT by 22% in the last year.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 51.33% to 51.81% in Sep 2024 quarter
Promoter Holding Up
Promoters have increased holdings from 45.28% to 45.44% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 68.5%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 42.3%
FII Holding Down
Foreign Institutions have decreased holdings from 3.40% to 2.75% in Sep 2024 quarter
Price Dip
In the last 1 month, AAREYDRUGS stock has moved down by -14.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 45.44% | 0.36 | |
Foreign Institutions | 2.75% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 51.81% | 0.94 | |
Others | 0% | 0.00 |
Aarey Drugs & Pharmaceuticals Ltd’s net profit jumped 30.08% since last year same period to ₹1.60Cr in the Q2 2024-2025. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated 29.03% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2018, Aarey Drugs & Pharmaceuticals Ltd has declared dividend of ₹0.10 - translating a dividend yield of 0.18%.
Read More about DividendsBearish
Neutral
Bullish
Aarey Drugs & Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) share price today is ₹54.69
Aarey Drugs & Pharmaceuticals Ltd is listed on NSE
Aarey Drugs & Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) is 5,413.00.
Today’s market capitalisation of Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) is ₹152.43Cr.
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS | Price |
---|---|
52 Week High | ₹74.8 |
52 Week Low | ₹37.35 |
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) share price is ₹54.69. It is down -26.89% from its 52 Week High price of ₹74.8
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) share price is ₹54.69. It is up 46.43% from its 52 Week Low price of ₹37.35
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS | Returns |
---|---|
1 Day Returns | 0.16% |
1 Month Returns | -14% |
3 Month Returns | -10.97% |
1 Year Returns | 16.27% |